Passage of cell-free extracts of rabbit reticulocytes through heparin-Sepharose affinity columns results in the loss of the ability of the effluent to initiate protein synthesis. This is shown by the loss of response to added rabbit globin mRNA or to inhibitors of initiation of protein synthesis, such as heparin and aurin tricarboxylic acid, and by recovery of initiation activity by addition of protein retained and subsequently eluted from the columns. The effluent retains, however, the ability to elongate protein chains. Only 0.8% of the applied cell extract protein binds to heparin-Sepharose columns. This bound protein, which can be recovered by increasing the salt concentration of the eluting buffer, has initiation factor activity equal to that of a crude initiation factor preparation obtained from rabbit reticulocyte ribosomes by extraction with 0.5 M KCI. The protein patterns on polyacrylamide gels of the initiation factors prepared by either method are very similar and indicate a protein mixture, which may represent a complex. These data confirm that heparin interacts specifically with initiation factors, and indicate that heparin-Sepharose chromatography will simplify procedures for the preparation of initiation factors.
Previous reports from this laboratory have established that heparin is a potent inhibitor of initiation of protein synthesis in a Krebs ascites cell-free system (1) (2) (3) (4) 6) , as well as in other mammalian cell-free systems (2, 4) . The inhibition is specific to heparin, with all other glycosaminoglycans tested being found inactive (1, 3, 5, 6) . The ability of heparin to inhibit initiation of protein synthesis is distinct from the ability of heparin to act as an anticoagulant. These activities exhibit different dependencies upon the degree of N-sulfation of the heparin molecule (5) . In addition, a number of naturally occurring heparins having low anticoagulant activity are fully potent as inhibitors of protein synthesis (unpublished observations).
The activity of heparin as an inhibitor of initiation of mammalian protein synthesis apparently involves interaction with initiation factors. This is indicated by the finding that the ability of a crude initiation factor (CiF) preparation, obtained by extraction of rabbit reticulocyte ribosomes with 0.5 M KCl, to stimulate exogenous-mRNA-dependent protein synthesis in a Krebs ascites cell-free system (7-10) is sensitive to heparin (6) .
Abbreviations: CIF, crude initiation factor; 8-30, 30,000 X g supernatant; ATA, aurin tricarboxylic acid. * Dedicated to the memory of Pierre L'Esperance, fellow scientist andfriend.
t To whom reprint requests should be addressed.
In order to confirm the interaction of heparin and initiation factors, we used heparin-Sepharose affinity chromatography, a method previously used to examine the specific interaction of heparin with lipoprotein lipase (11) and antithrombinheparin cofactor (12, 13) . Indeed, chromatography of CIF preparations on heparin-Sepharose affinity columns results in the binding of initiation factor activity (6) .
This report presents the results of studies using heparinSepharose columns to isolate material having initiation factor activity from whole cell extracts. Passage of the 30,000 X g supernatant derived from rabbit reticulocyte lysates (reticulocyte S-30) through heparin-Sepharose columns results in the selective binding of proteins active in initiation of protein synthesis, equal to 0.8% of the applied protein. The resultant reticulocyte S-30, while completely lacking the ability to initiate protein synthesis, retains the ability to elongate protein chains. Following salt elution of the columns, the bound initiation factor activity is recovered as a protein mixture, which may represent a complex. These data confirm that heparin interacts specifically with initiation factors. Furthermore, our results indicate that heparin-Sepharose chromatography is a useful technique that will simplify procedures for the preparation of initiation factors, and possibly allow a new approach to their characterization. Preparation and Incubation of Rabbit Reticulocyte S-30. Induction of reticulocytosis in rabbits and collection of rabbit reticulocytes were performed as previously described (17) . Reticulocytes were lysed and the 30,000 X g supernatant (reticulocyte S-30) was prepared by the method of Schreier and Staehelin (16) . Incubation under protein synthetic conditions of reticulocyte S-30 preparations, whether untreated or after Sepharose column chromatography, was essentially as described above for Krebs ascites cell-free extracts, except that final MgCl2 concentration was 2.5 mM, and the final KCl concentration was 60 mM.
Preparation of Rabbit Reticulocyte Globin mRNA. Induction of reticulocytosis in rabbits and collection of rabbit reticulocytes were performed as previously described (17) . Globin mRNA was isolated from rabbit reticulocytes by published procedures (18, 19) . Preparation of Heparin-Sepharose 4B Gel. Preparation of heparin-Sepharose 4B gels containing 0.53 mg of heparin covalently linked per ml of gel was performed according to the method of Pharmacia, using 1.2 mg of heparin per ml of gel. Control gels containing no heparin were prepared by deactivation of CNBr-activated Sepharose 4B with ethanolamine.
Chromatography of Rabbit Reticulocyte S-0 on HeparinSepharose. Five milliliters of rabbit reticulocyte S-30 (containing 250 mg of protein), prepared as noted above, was passed through 1 ml columns of heparin-Sepharose at room temperature. Following washing of the column with 6 ml of Buffer D containing 0.12 M KCl, any material bound to the column was recovered by increasing the KCl concentration of the eluting buffer. The column was washed with two 1 ml aliquots of Buffer D containing 0.5 M KCl, two 1 ml aliquots of Buffer D containing 1.0 M KCl, and two 1 ml aliquots of fractions against Buffer D containing 0.12 M KCl for 2 hr at 40, all fractions were analyzed for protein by the method of Lowry et al. (20) . Essentially all of the protein was found to be eluted by Buffer D containing 0.5 M KCl. The method is reproducible, and of the approximately 2.0-2.1 mg of protein recovered, the first 1 ml of eluent usually contains 1.9 mg of protein (approximately 0.8% of the applied protein). This fraction is referred to as fraction C.
Chromatography on control columns, using Sepharose containing no heparin, was performed similarly. Passage of rabbit reticulocyte S-30 through such control columns did not result in the binding of any protein. Previous studies (6) have shown that the proteins active in initiation do not interact with such columns, nor with columns containing heparin desulfated sufficiently to be inactive as an inhibitor of protein synthesis [this desulfated heparin still contains greater than two-thirds of the original sulfate groups (5) ].
The reticulocyte S-30, passed through either a heparinSepharose column or a control column, was incubated under protein synthetic conditions and the ability of the S-30 to incorporate L-[3H ]leucine into trichloroacetic-acid-insoluble protein was determined as described above.
Fraction C was assayed for initiation factor activity by determining its ability to stimulate added mRNA-dependent protein synthesis in the Krebs ascites cell-free systems described above.
RESULTS
Rabbit reticulocyte S-30 was passed through Sepharose columns containing either no heparin or 0.53 mg of heparin covalently bound per ml of gel. Material that bound to the columns was then recovered by increasing the KCl concentration of the eluting buffer from 0.12 M KCl to 0.5 M KCl (fraction C). Essentially no protein was recovered from the control column, while 1.9 mg was usually recovered in fraction C from the heparin-Sepharose column. This represents approximately 0.8% of the applied protein.
Fraction C was assayed for its ability to stimulate protein synthesis in a preincubated Krebs ascites cell-free system, in the presence and absence of added rabbit globin mRNA.
For comparison, a crude initiation factor (CIF) preparation, obtained by the method of Schreier and Staehelin (16) from 0.5 M KCl extracts of rabbit reticulocyte ribosomes, was also assayed. As presented in Table 1 , System 1, fraction C did not stimulate protein synthesis in the Krebs system in the absence of added mRNA, while the CIF preparation had some slight stimulatory effect. In the presence of added globin mRNA, however, addition of either fraction C or CIF resulted in marked stimulation of incorporation of L-[3H 1leucine into protein. On a weight to weight basis, fraction C had potency equal to the CIF preparation.
As endogenous protein synthesis in the preincubated Krebs ascites cell-free system represents essentially only elongation and termination of peptide chains (22) , the observation that fraction C does not stimulate the level of endogenous protein synthesis, while stimulating protein synthesis dependent upon added rabbit globin mRNA, indicated that the fraction was acting at the level of initiation of protein synthesis. This was further indicated by the similarity in the behavior of fraction C and CIF preparation, as such preparations have been shown to act only at the level of initiation of Buffer D containing 2.0 M KCl. Following dialysis of the Proc. Nat. Acad. Sci. USA 72 (1975) protein synthesis in the Krebs ascites cell-free system (7, 9) . (14) in the absence or presence of rabbit globin mRNA (20 jAg/ml) as noted. The CIF preparation and fraction C were obtained as described in Materials and Methods. Stimulation is defined as the increase in incorporation of L-[3H]leucine into trichloroacetic-acid-insoluble protein caused by each of the additions noted. The values represent an average obtained from two to five experiments. Incorporation in the absence of added rabbit globin mRNA was 6.6 X 104 cpm/ml, while incorporation in the presence of added rabbit globin was 19.0 X 104, levels comparable to those previously reported for this system (7, 9, 14, 21). The CIF preparation was added at 0-400 ,gg/ml and fraction C was added at 0-300 ,gg/ml.
Stimulation by each fraction was linear over the concentration range tested.
t The materials were added to the fractionated Krebs ascites cell-free protein synthetic system (15) in the absence or presence of rabbit globin mRNA (20 ,ug/ml) as noted. The CIF preparation used was a combination of fractions (15) derived from a parent CIF prepared by the method of Schreier and Staehelin (16) , and was a generous gift of Dr. J. B. Lewis. Fraction C was obtained from a heparin-Sepharose column as described in Materials and Methods. Stimulation is defined as for System 1. The values represent an average of two experiments. Incorporation in the absence or presence of added rabbit globin mRNA was approximately 16 pmol/ml. Fraction C was added at 0-800 ,g/ml, while the CIF preparation was added at the predetermined optimum concentration (a total of 1250 ,g/ml). Stimulation by fraction C was linear over the concentration range tested.
To further confirm that fraction C contained initiation factor activity, we assayed it in a fractionated cell-free system similar to that described by Schreier and Staehelin (16) . This protein synthetic system, reported by Anderson et al. (15) , is essentially completely dependent upon the presence of both exogenous mRNA and exogenous initiation factors, and consists of ribosome subunits and pH 5 fraction derived from Krebs ascites cell-free extracts. As presented in Table 1 , System 2, addition of fraction C to complete reaction mixtures resulted in marked stimulation of incorporation of L-[14C]-leucine into protein. On a weight to weight basis, fraction C was 70-75% as potent as the partially fractionated and recombined CIF preparation customarily used as a standard in this system (15) . Activity of the unfractionated CIF preparation (16) , which was used in System 1, was found to be highly variable in System 2.
Fraction C was electrophoresed on polyacrylamide gels, and the protein pattern was compared to that of the original reticulocyte lysate and to that of the reticulocyte CIF prepa- Protein (100 jAg) was applied to gel 1 to allow definition of nonglobin protein bands. Protein (50 jug each) was applied to gels 2 and 3. Gels were stained with 0.05% Coomassie blue. For further details, see Materials and Methods. ration. As seen in Fig. 1 , the reticulocyte S-30 contains a number of proteins, the predominant one being globin (Fig. 1,  gel 1) . The protein pattern of fraction C (Fig. 1, gel 2) , which is quite complex, differs sharply from that of the parent reticulocyte S-30, but is markedly similar to that observed for the CIF preparation (Fig. 1, gel 3) .
To confirm that passage of the reticulocyte S-30 through heparin-Sepharose affinity columns resulted in the binding of the initiation factor activity contained in the extract, we examined the material passed through either a control column or a heparin-Sepharose column for protein synthetic ability. As presented in Table 2 , reticulocyte S-30 that had passed through a heparin-Sepharose affinity column had markedly decreased ability to incorporate -[3H]Ileucine into protein, and markedly reduced response to added rabbit globin mRNA, when compared either to untreated reticulocyte S-30 or reticulocyte S-30 passed through a control column. The latter two materials exhibited similar protein synthetic capacity. Such differences would be expected if passage through heparin-Sepharose affinity columns had removed the ability of the reticulocyte S-30 to initiate protein synthe-S1S.
The response of each of the reticulocyte S-30 extracts (untreated, control column pass-through, and heparin-Sepharose column pass-through) to thesis, heparin (1, 3) and aurin tricarboxylic acid (ATA) (24), was examined. As seen in Fig. 2A and B, addition of either heparin or ATA to assay mixtures containing untreated reticulocyte S-30 or reticulocyte S-30 passed through a control column containing no heparin resulted in markedly decreased protein synthesis. Protein synthesis in assay mixtures containing reticulocyte S-30 passed through a heparinSepharose affinity column was essentially unaffected by the presence of heparin or ATA, indicating that the incorporation of L-[3H]leucine into protein observed with this extract represented only elongation and termination of peptide chains. At appropriate levels of either inhibitor, the level of protein synthesis for all three reticulocyte S-30 extracts was essentially the same (heparin at 40 ug/ml, Fig. 2A ; ATA at 100 uM, Fig. 2B ). These data indicate that simply by inhibition of initiation, the level of protein synthesis in both the untreated and control column pass-through S-30 could be reduced to the level of the heparin column pass-through S-30. This suggests that only initiation ability was lost from the heparin column pass-through and that this loss accounted for its lower protein synthetic capacity. As presented in Table 3 , addition of either CIF preparation or fraction C resulted in the restoration of the level of protein synthesis in the heparin column pass-through S-30 to that of the untreated S-30 (see ratio). These results eliminated the possibility that the heparin column pass-through S-30 had been irreversibly inhibited. In addition, since CIF restores the protein synthetic capacity of the heparin column pass-through S-30, these data tend to confirm that initiation factors had been removed from the heparin column pass-through S-30.
Addition of either CIF or fraction C also stimulated protein synthesis in the untreated S-30. The reason for this stimulation, which is repeatedly observed, is as yet unknown.
DISCUSSION
The isolation of initiation factors from the whole cell extracts by means of heparin-Sepharose affinity columns is quite rapid and can be performed in half a day. Very little starting material is necessary, the yield of initiation factor activity is quite high, and manipulation of either starting material or initiation factor is minimized. In addition, the whole cell extract is still active in the elongation of protein chains after chromatography on heparin-Sepharose affinity columns. Therefore, this procedure allows for the rapid preparation not only of initiation factors but also of extracts depleted in initiation factors, and should prove useful in the study of the role of initiation factors in the control of protein synthesis.
It is possible that a protein complex might be the native, active form of initiation factors. This suggestion is supported Incorporation is defined as for by the results of studies on the interaction of CIF preparations with heparin-Sepharose affinity columns (6) and by reports from other laboratories which have implicated protein complexes in the initiation process. Cashion and Stanley (25) have reported two initiation factors of molecular weight 150,-000 and 220,000 which are usually isolated as a complex, while Schreier and Staehelin have reported an initiation factor activity with a sedimentation rate of 19 S (26) . In addition, a number of proteins of lower molecular weight have also been found to be active in initiation of mammalian protein synthesis (27) (28) (29) . Whether fraction C has all initiation factors or not, the similarity in the protein patterns of the initiation factor activity of rabbit reticulocytes obtained either by chromatography of reticulocyte S-30 on heparin-Sepharose affinity columns or by KCl extraction of reticulocyte ribosomes (16) strengthens the argument that a protein complex is involved in the initiation process. It has previously been established that heparin is a potent and specific inhibitor of initiation of mammalian protein synthesis in cell-free systems (1) (2) (3) (4) (5) (6) . The ability of the heparin to interact with the active fraction of reticulocyte CIF preparations (6) indicated that such interaction might explain heparin's action as a protein synthesis inhibitor. The data presented in this report using reticulocyte lysates further support the concept that heparin acts to inhibit initiation of protein synthesis by binding to initiation factors. Preliminary experiments indicate that similar interactions occur when Krebs ascites cell-free extracts are examined, again suggesting that such binding is the mechanism of heparin action. Whether heparin has a similar site of action in vivo is not yet known.
